(Rac)-3-(3,5-Dimethylphenyl)-3-(5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentanamido)propanoic acid

ID: ALA3356182

Chembl Id: CHEMBL3356182

PubChem CID: 118721341

Max Phase: Preclinical

Molecular Formula: C24H31N3O3

Molecular Weight: 409.53

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C)cc(C(CC(=O)O)NC(=O)CCCCc2ccc3c(n2)NCCC3)c1

Standard InChI:  InChI=1S/C24H31N3O3/c1-16-12-17(2)14-19(13-16)21(15-23(29)30)27-22(28)8-4-3-7-20-10-9-18-6-5-11-25-24(18)26-20/h9-10,12-14,21H,3-8,11,15H2,1-2H3,(H,25,26)(H,27,28)(H,29,30)

Standard InChI Key:  GWYITMXKBHRSJF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3356182

    ---

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-6 (509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-5 (589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-8 (181 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 409.53Molecular Weight (Monoisotopic): 409.2365AlogP: 4.10#Rotatable Bonds: 9
Polar Surface Area: 91.32Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 4.63CX Basic pKa: 7.52CX LogP: 1.98CX LogD: 1.76
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.54Np Likeness Score: -0.21

References

1. Adams J, Anderson EC, Blackham EE, Chiu YW, Clarke T, Eccles N, Gill LA, Haye JJ, Haywood HT, Hoenig CR, Kausas M, Le J, Russell HL, Smedley C, Tipping WJ, Tongue T, Wood CC, Yeung J, Rowedder JE, Fray MJ, McInally T, Macdonald SJ..  (2014)  Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.,  (11): [PMID:25408832] [10.1021/ml5002079]

Source